References
- Goad K E, Gralnick H R. Coagulation Disorders in Cancer. Hematol/Oncol Clin North Am 1996; 10: 457–484
- Özsoylu S. High dose intravenous methylpredniso‐lone (HIVMP) in haematologic disorders. Hematol Rev 1990; 4: 197–207
- Hiçsönmez G, Gümriik F, Zamani P V, et al. High‐dose meth‐ylprednisolone for children with acute lymphoblastic leukemia and unfavorable presenting features. Eur J Haematol 1997; 58: 26–31
- Picton Thomas. Complications of steroid and ACTH therapy. Guide to steroid therapy, P Thomas. Lloyd‐Luke Ltd., England 1968; 47–61
- Mitchell L, Halton J, Vegh P A, Barr R D, Veneri T, Pai M K, Andrew M E. Effect of disease and chemotherapy on hemostasia in children with acute lymphoblastic leukemia. Am J Hematol Oncol 1994; 16: 120–125
- Gugliotta L, Mazzucconi M G, Leone G. Incidence of thrombotic complications in adult patients with acute lymphoid leukemia receiving L‐asparaginase during induction therapy: A retrospective study. Eur J Haematol 1992; 49: 63–66
- Mitchell L, Hoogendoorn H, Giles A R, Vegh P, Andrew M. Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L‐Asparaginase‐induced antithrombin III deiciency. Blood 1994; 83: 386–391
- Pui C H, Chesney C M, Bergum P W, Jackson C W, Rapa‐port S I. Lack of pathogenetic role of proteins C and S in thrombosis associated with asparaginase‐prednisone‐vincristine therapy for leukemia. Br J Haematol 1986; 64: 283–290
- Rivera G K, Riamondi S C, Hancock M L, Behm F G, Pui C H, Abromowitch M, Mirro J, Jr, Osch J S, Look A T, Williams D L, Murphy S B, Dahl G V, Kalwinsky D K, Evans W E, Kun L E, Simone J V, Crist W M. Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy. Lancet 1991; 337: 61–66
- Abshire T, Gold S, Odom L F, Carson S D, Hathaway W E. The coagulopathy of childhood leukemia. Thrombin activation or primary fibrinolysis?. Cancer 1990; 66: 746–72
- Bick L B. Hypercoagulability and thrombosis. In Bick RL. Common bleeding and clotting disorders for the internist. Med Clin North Am 1994; 78: 635–665
- Bobbeli T, Mueller M, Haeberli A. Anticoagulant properties of vascular endothelium. Thromb Haemost. 1997; 77: 408–423
- Ohdama S, Tokano S, Miyake S, et al. Plasma thrombomodulin as a marker of vascular injuries in collagen vascular disorders. Am J Clin Pathol 1994; 101: 109–113
- Alessio M G, Falanga A, Consonni R, et al. Cancer procoagulant in acute lymphoblastic leukemia. Eur J Haematol 1990; 45: 78–83